Intel ran hard. From under $25 a year ago to a June 22 peak of $140.94, the stock delivered a 400% gain in twelve months. Now it sits around $95.80, down about 32% from that high.
That pullback has Wall Street asking the obvious question: buying opportunity or value trap?
Mizuho’s Vijay Rakesh, ranked 12th out of 12,498 analysts on TipRanks with a 64% success rate, just weighed in. He lowered his price target from $109 to $92 while keeping a Hold rating. At current prices, he essentially sees Intel as fairly valued, not a screaming sell.
The drop from the peak came in three waves. First, a sector-wide rotation in early July after Bank of America and Morgan Stanley flagged that AI chip valuations had outrun near-term demand. Second, an 8% post-earnings drop despite a blowout Q2 report, as investors were rattled by a GAAP diluted loss of $2.16 per share tied to restructuring charges and the absence of committed external foundry customers. Third, the August equity raise of $15 billion, which was necessary for Intel’s infrastructure buildout but hit existing holders through dilution.
The Q2 numbers themselves were hard to argue with. Revenue came in at $16.13 billion, beating the $14.43 billion consensus by nearly $1.7 billion. EPS of $0.42 doubled the $0.21 estimate. The Data Center and AI segment grew 59% year over year to $6.3 billion. Foundry revenue rose 31% to $5.8 billion.
CEO Lip-Bu Tan called it Intel’s “strongest revenue growth in more than fifteen years.”
But the market’s reaction showed what investors are really focused on: not where Intel is today, but whether the foundry business can attract committed outside customers at scale.
Rakesh isn’t dismissing the bull case. He sees CPU-to-GPU ratios potentially improving from 1:4 today to 1:1 long term as agentic AI grows. Server CPU supply remains tight through 2027. Advanced packaging revenue could reach $3.5 billion by 2029, with external foundry revenue potentially adding another $3.5 billion as the 14A node matures.
He also flagged early signs of a PC corporate refresh cycle, supported by recent commentary from Dell.
CEO Lip-Bu Tan purchased 105,263 Intel shares on August 11 at $95 per share, totaling roughly $10 million. That brought his stake to over 1.3 million shares. Primecap Management also opened a new position worth over $10.5 billion in Q2.
On the other side, Nan Shan Life Insurance cut its Intel position by 56.9% in Q2, selling 222,786 shares.
Wall Street’s consensus across 31 analysts is Hold, with an average price target of $107.01. Rakesh at $92 sits at the cautious end of that range.
Intel has set Q3 2026 EPS guidance at $0.38, with full-year analyst estimates at $1.01 per share.
The post Intel (INTC) Stock: What a Top Analyst Sees After the 32% Pullback appeared first on CoinCentral.